Citigroup Inc View Ray, Inc. Transaction History

Citigroup Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$0.35 - $3.28 $173,111 - $1.62 Million	-494,603 Reduced 91.73%	44,576 $15,000
Q1 2023 May 11, 2023	BUY	$3.28 - $4.81 $1.75 Million - $2.57 Million	534,800 Added 12212.83%	539,179 $1.87 Million
Q4 2022 Feb 09, 2023	SELL	$3.65 - $4.82 $4,361 - $5,759	-1,195 Reduced 21.44%	4,379 $19,000
Q3 2022 Nov 10, 2022	SELL	$2.66 - $3.97 $20,479 - $30,565	-7,699 Reduced 58.0%	5,574 $20,000
Q2 2022 Aug 10, 2022	BUY	$2.42 - $4.05 $9,091 - $15,215	3,757 Added 39.48%	13,273 $36,000
Q1 2022 May 12, 2022	SELL	$3.45 - $5.83 $121,615 - $205,513	-35,251 Reduced 78.74%	9,516 $37,000
Q4 2021 Feb 10, 2022	BUY	$4.89 - $7.59 $130,919 - $203,207	26,773 Added 148.79%	44,767 $247,000
Q3 2021 Nov 10, 2021	BUY	$5.18 - $7.41 $93,208 - $133,335	17,994 New	17,994 $130,000

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.